Alderman M H, Madhavan S, Ooi W L, Cohen H, Sealey J E, Laragh J H
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, N.Y. 10461-1602.
N Engl J Med. 1991 Apr 18;324(16):1098-104. doi: 10.1056/NEJM199104183241605.
To test the prognostic value of plasma renin activity prospectively, we determined the pretreatment renin-sodium profile of 1717 subjects with mild-to-moderate hypertension (mean age, 53 years; 36 percent white; 67 percent men) in a systematic work-site treatment program.
Renin profiles, obtained by plotting plasma renin activity against the urinary excretion of sodium, were classified as high (12 percent of the subjects), normal (56 percent), and low (32 percent), and there were expected variations according to age, sex, and race. Modified stepped-care treatment for hypertension, prescribed without reference to the renin profile, was similar in the three renin groups.
Mean (+/- SD) blood pressure at entry was 151 +/- 19/100 +/- 10 mm Hg in the subjects with a high renin profile, 151 +/- 19/97 +/- 10 mm Hg in those with a normal profile, and 151 +/- 20/96 +/- 11 mm Hg in those with a low profile. During 8.3 years of follow-up, there were 27 myocardial infarctions. As adjusted for age, sex, and race, the incidence of myocardial infarction per 1000 person-years was 14.7 among the subjects with a high renin profile, 5.6 among those with a normal profile, and 2.8 among those with a low profile (rate ratio for high vs. low, 5.3; 95 percent confidence interval, 3.4 to 8.3). The rate of mortality from all causes was 9.3 in the high-profile group, 5.3 in the normal-profile group, and 3.9 in the low-profile group. The independent association of a high renin profile with myocardial infarction (but not with stroke or noncardiovascular events) was affirmed by Cox analyses (rate ratio for high vs. normal plus low, 3.2; 95 percent confidence interval, 1.2 to 8.4) after adjustment for race, sex, age at entry, serum cholesterol level, smoking status, electrocardiographic evidence of left ventricular hypertrophy, blood glucose level, body-mass index, history of cardiovascular disease or treatment, blood pressure, and use of beta-blockers.
In the study population, whose blood pressure before and during treatment was in a narrow range, and after other cardiovascular risk factors had been considered, the renin profile before treatment remained independently associated with the subsequent risk of myocardial infarction.
为前瞻性地检验血浆肾素活性的预后价值,我们在一项系统性的工作场所治疗项目中,测定了1717例轻至中度高血压患者(平均年龄53岁;36%为白人;67%为男性)的治疗前肾素-钠谱。
通过绘制血浆肾素活性与尿钠排泄量的关系获得肾素谱,分为高肾素谱(12%的受试者)、正常肾素谱(56%)和低肾素谱(32%),且根据年龄、性别和种族存在预期差异。未参考肾素谱而开具的改良阶梯式高血压治疗方案在三个肾素组中相似。
高肾素谱组患者入组时的平均(±标准差)血压为151±19/100±10 mmHg,正常肾素谱组为151±19/97±10 mmHg,低肾素谱组为151±20/96±11 mmHg。在8.3年的随访期间,发生了27例心肌梗死。在对年龄、性别和种族进行校正后,每1000人年的心肌梗死发生率在高肾素谱组中为14.7,正常肾素谱组中为5.6,低肾素谱组中为2.8(高肾素谱组与低肾素谱组的率比为5.3;95%置信区间为3.4至8.3)。全因死亡率在高肾素谱组中为9.3,正常肾素谱组中为5.3,低肾素谱组中为3.9。在对种族、性别、入组时年龄、血清胆固醇水平、吸烟状况、左心室肥厚的心电图证据、血糖水平、体重指数、心血管疾病史或治疗史、血压以及β受体阻滞剂的使用进行校正后,Cox分析证实高肾素谱与心肌梗死(而非中风或非心血管事件)存在独立关联(高肾素谱组与正常肾素谱组加低肾素谱组的率比为3.2;95%置信区间为1.2至8.4)。
在该研究人群中,治疗前和治疗期间的血压处于较窄范围,且在考虑了其他心血管危险因素后,治疗前的肾素谱仍与随后发生心肌梗死的风险独立相关。